Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

Clinical Trials

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

HPGD-ccRCC

ENPP1-BC

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

AREG, EREG and EGFR: Response to Anti-EGFR Agents in Colorectal Cancer

Significance of Immunohistochemical Expression of Fascin-1 in Colorectal Carcinoma

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Diagnostic and Prognostic Value of PTEN Expression in Functional and Pathological Endometrial Biopsies

Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

Biomarkers in Patients With Stage III or Stage IV Follicular Lymphoma Treated on Clinical Trial E-1496

EPNEC

S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma

PACE4 in Thyroid Cancer

GLUT1

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery

Protein and RNA Expression Patterns in Predicting Response to Treatment in Patients With Lung Cancer

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803

Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer

Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690

Biomarkers in Samples From Patients With Follicular Lymphoma Treated With Rituximab

Biomarkers in Tissue Samples From Patients With Breast Cancer Treated With Bevacizumab

Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab

Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy

Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397

Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301

Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants

Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer

Study of Proteins in Head and Neck Cancer Cells

S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911

Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

Studying Gene Expression in Samples From Patients With Rhabdoid Tumors

Biomarkers in Native American Women With Breast Cancer

Biomarker in Tissue Samples From Patients With Ewing Sarcoma

Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma

Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer

Biomarker in Tumor Tissue Samples From Patients With Rhabdomyosarcoma

Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

Protein Expression in Samples From Young Patients With Rhabdomyosarcoma

Studying Biomarkers in Samples From Younger Patients With Wilms Tumor

Studying Gene Expression and Location in Samples From Patients With Brain Tumors

Protein Biomarker Levels in Tissue Samples From Young Patients With Low-risk Hodgkin Lymphoma

Biomarkers in Samples From Young Patients With Neuroblastoma

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer